Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
immune response
biological product |
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:alternativeName |
gptkb:Vaccinia_Immune_Globulin_Intravenous
gptkb:VIG |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:category |
antiviral drug
immunotherapy |
| gptkbp:contraindication |
IgA deficiency with antibodies against IgA
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vaccinia Immune Globulin
|
| gptkbp:notEffectiveAgainst |
postexposure prophylaxis of smallpox
treatment of uncomplicated vaccinia |
| gptkbp:producedBy |
plasma of individuals vaccinated with vaccinia virus
|
| gptkbp:relatedTo |
gptkb:vaccinia_virus
smallpox vaccine |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
fever
nausea headache chills allergic reactions |
| gptkbp:storage |
refrigerated
|
| gptkbp:usedFor |
treatment of accidental implantation
treatment of eczema vaccinatum treatment of progressive vaccinia treatment of severe generalized vaccinia treatment of complications from vaccinia vaccination |
| gptkbp:bfsParent |
gptkb:Cangene_Corporation
|
| gptkbp:bfsLayer |
6
|